Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Beyond Air, Inc. | Director | Common Stock | 1.48M | $745K | $0.50 | Sep 26, 2024 | The Carey 2020 Acelyrin Trust DTD 07/23/2020 |
SANGAMO THERAPEUTICS, INC | Director | Common Stock | 74.6K | $44.8K | $0.60 | Jun 4, 2024 | Direct |
Beyond Air, Inc. | Director | Warrants to purchase Common Stock | 9.89M | Sep 27, 2024 | By: BCR8V, LLC | ||
Beyond Air, Inc. | Director | Warrants to purchase Common Stock | 1.88M | Sep 26, 2024 | By: Robert F. Carey III Trust DTD 4/25/01 | ||
Beyond Air, Inc. | Director | Warrants (right to buy) | 602K | Mar 20, 2024 | Direct | ||
Beyond Air, Inc. | Director | Pre-funded Warrants to purchase Common Stock | 480K | Sep 26, 2024 | By: Robert F. Carey III Trust DTD 4/25/01 | ||
Beyond Air, Inc. | Director | Warrants to purchase Common Stock | 102K | Sep 26, 2024 | By: The Carey 2020 Acelyrin Trust DTD 07/23/2020 | ||
Beyond Air, Inc. | Director | Stock Option (right to buy) | 90K | Mar 20, 2024 | Direct | ||
SANGAMO THERAPEUTICS, INC | Director | Stock Option (Right to Buy) | 50K | Jun 4, 2024 | Direct | ||
Beyond Air, Inc. | Director | Pre-funded Warrants to purchase Common Stock | 26.1K | Sep 26, 2024 | By: The Carey 2020 Acelyrin Trust DTD 07/23/2020 | ||
Beyond Air, Inc. | Director | Stock Options (Right to buy) | 25K | Nov 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XAIR | Beyond Air, Inc. | Nov 22, 2024 | 14 | $0 | 4 | Nov 26, 2024 | Director |
XAIR | Beyond Air, Inc. | Sep 26, 2024 | 6 | $745K | 4 | Oct 1, 2024 | Director |
XAIR | Beyond Air, Inc. | Aug 14, 2024 | 1 | $39.7K | 4 | Aug 15, 2024 | Director |
SGMO | SANGAMO THERAPEUTICS, INC | Jun 4, 2024 | 2 | $0 | 4 | Jun 6, 2024 | Director |
XAIR | Beyond Air, Inc. | Mar 20, 2024 | 1 | $0 | 4 | Mar 21, 2024 | Director |
XAIR | Beyond Air, Inc. | Mar 20, 2024 | 2 | $1M | 4 | Mar 21, 2024 | Director |
XAIR | Beyond Air, Inc. | Dec 18, 2023 | 1 | $1.96M | 4 | Dec 19, 2023 | Director |
XAIR | Beyond Air, Inc. | Aug 28, 2023 | 1 | $674K | 4 | Aug 29, 2023 | Director |
XAIR | Beyond Air, Inc. | Aug 18, 2023 | 2 | $243K | 4 | Aug 22, 2023 | Director |
SGMO | SANGAMO THERAPEUTICS, INC | Jun 1, 2023 | 2 | $0 | 4 | Jun 5, 2023 | Director |
XAIR | Beyond Air, Inc. | Mar 31, 2023 | 3 | $0 | 5 | Dec 14, 2023 | Director |
XAIR | Beyond Air, Inc. | Mar 29, 2023 | 1 | $0 | 4 | Mar 31, 2023 | Director |
XAIR | Beyond Air, Inc. | Mar 29, 2023 | 2 | $128K | 4 | Mar 30, 2023 | Director |
XAIR | Beyond Air, Inc. | Mar 13, 2023 | 2 | $94.2K | 4 | Mar 15, 2023 | Director |
XAIR | Beyond Air, Inc. | Mar 8, 2023 | 1 | $59.5K | 4 | Mar 9, 2023 | Director |
XAIR | Beyond Air, Inc. | Dec 7, 2022 | 1 | $115K | 4 | Dec 9, 2022 | Director |
XAIR | Beyond Air, Inc. | Nov 28, 2022 | 2 | $172K | 4 | Nov 30, 2022 | Director |
XAIR | Beyond Air, Inc. | Nov 16, 2022 | 3 | $294K | 4 | Nov 18, 2022 | Director |
XAIR | Beyond Air, Inc. | Jun 30, 2022 | 1 | $1.13M | 4 | Jul 5, 2022 | Director |
XAIR | Beyond Air, Inc. | Apr 5, 2022 | 1 | $134K | 4 | Apr 6, 2022 | Director |
XAIR | Beyond Air, Inc. | Mar 24, 2022 | 2 | $174K | 4 | Mar 28, 2022 | Director |
XAIR | Beyond Air, Inc. | Mar 17, 2022 | 1 | $135K | 4 | Mar 21, 2022 | Director |
XAIR | Beyond Air, Inc. | Mar 3, 2022 | 1 | $0 | 4 | Mar 7, 2022 | Director |
SGMO | SANGAMO THERAPEUTICS, INC | Feb 25, 2022 | 2 | $0 | 4 | Mar 1, 2022 | Director |
XAIR | Beyond Air, Inc. | Dec 22, 2021 | 1 | $95K | 4 | Dec 27, 2021 | Director |
XAIR | Beyond Air, Inc. | Nov 23, 2021 | 1 | $61.8K | 4 | Nov 26, 2021 | Director |
XAIR | Beyond Air, Inc. | Nov 22, 2021 | 1 | $121K | 4 | Nov 24, 2021 | Director |
XAIR | Beyond Air, Inc. | Nov 19, 2021 | 1 | $169K | 4 | Nov 23, 2021 | Director |
XAIR | Beyond Air, Inc. | Jun 17, 2021 | 1 | $1.88M | 4 | Jun 21, 2021 | Director |
XAIR | Beyond Air, Inc. | Mar 31, 2021 | 1 | $0 | 5 | Feb 18, 2022 | Director |